PolyNovo announced the approval of NovoSorb BTM by the Taiwan FDA for sale in Taiwan. In order to start selling, Evermed needs to lodge reimbursement data with the health authority, typically a three-month process, to achieve billing codes for use by the hospitals. First sales are anticipated circa March 2021.